• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

药物警戒方面的培训与教育：来自印度药物警戒计划的经验。

Training and education in pharmacovigilance: The experience from the Pharmacovigilance Programme of India.

作者信息

Kumar Rishi, Prakash Jai, Bhushan Shashi, Rawat Akash Deep, Ray R S, Raghuvanshi Rajeev Singh

机构信息

National Coordination Centre for Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India.

出版信息

Indian J Pharmacol. 2024 Sep 1;56(5):348-357. doi: 10.4103/ijp.ijp_638_22. Epub 2024 Dec 16.

DOI:10.4103/ijp.ijp_638_22
PMID:39687959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698288/
Abstract

For a robust Pharmacovigilance system in a country, training of healthcare professionals is of utmost importance. The training is the integral part of continual improvement in any quality management system. The present article describes the different training modules and experience from the Pharmacovigilance Programme of India (PvPI) and emphasizes that if training and education elements with special reference to pharmacovigilance are implemented for all concerned stakeholders in a healthcare system, the efficiency of deliverables will be improved and objectives of the organization can easily be achieved. The PvPI has been putting its best efforts to train healthcare professionals in pharmacovigilance and it has achieved new heights in establishing best practices for the other countries to follow for the development of pharmacovigilance system in their respective countries or regions. The aim of this article is to suggest how capacity building in a pharmacovigilance system can help low- and middle-income countries in area of pharmacovigilance. The authors tried to conceptualize the process and implementation of the training program under PvPI.

摘要

对于一个国家强大的药物警戒系统而言，医疗保健专业人员的培训至关重要。培训是任何质量管理体系持续改进的不可或缺部分。本文描述了印度药物警戒计划（PvPI）的不同培训模块和经验，并强调如果针对医疗保健系统中的所有相关利益者实施特别涉及药物警戒的培训和教育内容，可交付成果的效率将得到提高，组织目标也能轻松实现。PvPI一直在尽最大努力培训医疗保健专业人员进行药物警戒，并且在为其他国家建立最佳实践以在各自国家或地区发展药物警戒系统方面达到了新高度。本文旨在提出药物警戒系统中的能力建设如何能在药物警戒领域帮助低收入和中等收入国家。作者试图对PvPI下培训计划的流程和实施进行概念化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/e1d9d7cbfee2/IJPharm-56-348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/9240153df391/IJPharm-56-348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/b8073a1b4f17/IJPharm-56-348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/da47b4527bb6/IJPharm-56-348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/7531e8c60331/IJPharm-56-348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/e1d9d7cbfee2/IJPharm-56-348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/9240153df391/IJPharm-56-348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/b8073a1b4f17/IJPharm-56-348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/da47b4527bb6/IJPharm-56-348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/7531e8c60331/IJPharm-56-348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2d3/11698288/e1d9d7cbfee2/IJPharm-56-348-g005.jpg

相似文献

1
Training and education in pharmacovigilance: The experience from the Pharmacovigilance Programme of India.药物警戒方面的培训与教育：来自印度药物警戒计划的经验。
Indian J Pharmacol. 2024 Sep 1;56(5):348-357. doi: 10.4103/ijp.ijp_638_22. Epub 2024 Dec 16.
2
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验：对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
3
Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.低收入和中等收入国家的药物警戒流程：从数据收集转向数据分析与解读
Ther Adv Drug Saf. 2025 Jun 11;16:20420986241300006. doi: 10.1177/20420986241300006. eCollection 2025.
4
Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries.建立功能完善且可持续的药物警戒系统：对高、中、低收入国家药物警戒发展情况的分析
Ther Adv Drug Saf. 2025 Jun 10;16:20420986251342941. doi: 10.1177/20420986251342941. eCollection 2025.
5
Community views on mass drug administration for soil-transmitted helminths: a qualitative evidence synthesis.社区对土壤传播蠕虫群体药物给药的看法：定性证据综合分析
Cochrane Database Syst Rev. 2025 Jun 20;6:CD015794. doi: 10.1002/14651858.CD015794.pub2.
6
Perceptions and experiences of the prevention, detection, and management of postpartum haemorrhage: a qualitative evidence synthesis.预防、检测和管理产后出血的认知和经验：定性证据综合。
Cochrane Database Syst Rev. 2023 Nov 27;11(11):CD013795. doi: 10.1002/14651858.CD013795.pub2.
7
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊：ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
8
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验：定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
9
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.影响重症成人和儿童机械通气撤机方案使用的因素：一项定性证据综合分析
Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2.
10
Affordable Cardiac Rehabilitation An Outreach Inter-Disciplinary Strategic Study (ACROSS) - Research Programme Protocol.平价心脏康复——一项拓展性跨学科战略研究（ACROSS）——研究计划方案
NIHR Open Res. 2025 May 6;5:41. doi: 10.3310/nihropenres.13957.1. eCollection 2025.

本文引用的文献

1
Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study.印度中部一个药物不良反应监测中心的药物不良反应监测：一项为期 7 年的监测研究。
BMJ Open. 2021 Oct 4;11(10):e052737. doi: 10.1136/bmjopen-2021-052737.
2
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.通过培训和指导加强撒哈拉以南非洲的药物警戒：GSK 在马拉维的试点计划。
Drug Saf. 2020 Jun;43(6):583-593. doi: 10.1007/s40264-020-00925-4.
3
Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication.
巴西药物警戒法规的协调统一：改善风险沟通的机会。
Clin Ther. 2019 Mar;41(3):598-603. doi: 10.1016/j.clinthera.2019.01.013. Epub 2019 Feb 18.
4
Current state of biologic pharmacovigilance in the European Union: improvements are needed.欧盟生物药物警戒的现状：需要改进。
Expert Opin Drug Saf. 2019 Mar;18(3):231-240. doi: 10.1080/14740338.2019.1577818. Epub 2019 Feb 27.
5
Best Practices for Improving the Quality of Individual Case Safety Reports in Pharmacovigilance.提高药物警戒中个体病例安全性报告质量的最佳实践
Ther Innov Regul Sci. 2016 Jul;50(4):464-471. doi: 10.1177/2168479016634766.
6
Adverse drug reactions.药物不良反应。
Anaesthesia. 2018 Jan;73 Suppl 1:76-84. doi: 10.1111/anae.14143.
7
A global view of undergraduate education in pharmacovigilance.药物警戒本科教育的全球视野。
Eur J Clin Pharmacol. 2017 Jul;73(7):891-899. doi: 10.1007/s00228-017-2237-z. Epub 2017 Mar 17.
8
Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.探索执业护士教育的概念和理论框架：一项范围综述方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):146-55. doi: 10.11124/jbisrir-2015-2150.
9
Implementation of an interprofessional educational model.实施跨专业教育模式。
Nurse Educ. 2013 Nov-Dec;38(6):261-4. doi: 10.1097/01.NNE.0000435271.40151.23.
10
Training in Post-authorization Pharmacovigilance.上市后药物警戒培训
Perspect Clin Res. 2010 Apr;1(2):70-5.